2026 Global Biopharmaceutical M&A and VC Insights
January 9, 2026
Alvarez & Marsal is proud to release the 2025 Global Biopharmaceutical M&A and VC Insights Report.
A Closer Look at the Life Sciences Industry: 2025 Life Sciences Report
December 18, 2025
A&M is pleased to present a copy of our 2025 Health of the Life Sciences Industry Report.
Where AI Meets Financial Impact
December 8, 2025
CFOs are uniquely positioned to lead the charge on value creation, leveraging emerging technologies to unlock deeper insights and optimise business decisions. This article explores the transformative potential of AI for financial impact and strategic decision-making.
M&A commentary: Surge in value of deals
December 3, 2025
The ONS data shows M&A activity Q3 remained low, however, since September we’ve seen an uptick. The market seems to have shrugged off market disruption and restarted in earnest. Mike Trenouth provides comments on the latest data release.